scholarly journals Colorectal cancer screening interventions in 2 health care systems serving disadvantaged populations: Screening uptake and cost-effectiveness

Cancer ◽  
2018 ◽  
Vol 124 (21) ◽  
pp. 4130-4136 ◽  
Author(s):  
Christen L. Lara ◽  
Kelly L. Means ◽  
Krystal D. Morwood ◽  
Westley R. Lighthall ◽  
Sonja Hoover ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Health Care ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Health Care Systems ◽  
Screening Uptake ◽  
Disadvantaged Populations ◽  
Care Systems

scholarly journals Increasing Colorectal Cancer Screening in Health Care Systems Using Evidence-Based Interventions

2018 ◽  
Vol 15 ◽  
Author(s):  
Amy DeGroff ◽  
Krishna Sharma ◽  
Anamika Satsangi ◽  
Kristy Kenney ◽  
Djenaba Joseph ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Health Care ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Health Care Systems ◽  
Evidence Based ◽  
Care Systems

scholarly journals Organized Colorectal Cancer Screening in Integrated Health Care Systems

2011 ◽  
Vol 33 (1) ◽  
pp. 101-110 ◽  
Author(s):  
T. R. Levin ◽  
L. Jamieson ◽  
D. A. Burley ◽  
J. Reyes ◽  
M. Oehrli ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Health Care ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Health Care Systems ◽  
Integrated Health Care ◽  
Integrated Health Care Systems ◽  
Integrated Health ◽  
Care Systems

Costs and Cost Effectiveness of a Health Care Provider–Directed Intervention to Promote Colorectal Cancer Screening Among Veterans

2005 ◽  
Vol 23 (34) ◽  
pp. 8877-8883 ◽  
Author(s):  
Michael S. Wolf ◽  
Karen A. Fitzner ◽  
Eowyn F. Powell ◽  
Kathryn R. McCaffrey ◽  
A. Simon Pickard ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Health Care ◽  
Information Technology ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Health Care Provider ◽  
Care Provider ◽  
Sensitivity Analyses ◽  
The Cost

Purpose Colorectal cancer screening is underused, particularly in the Veterans Affairs (VA) population. In a randomized controlled trial, a health care provider–directed intervention that offered quarterly feedback to physicians on their patients' colorectal cancer screening rates led to a 9% increase in colorectal cancer screening rates among veterans. The objective of this secondary analysis was to assess the cost effectiveness of the colorectal cancer screening promotion intervention. Methods Providers in the intervention arm attended an educational workshop on colorectal cancer screening and received confidential feedback on individual and group-specific colorectal cancer screening rates. The primary end point was completion of colorectal cancer screening tests. Sensitivity analyses investigated cost-effectiveness estimates varying the data collection methods, costs of labor and technology, and the effectiveness of the intervention. Results Rates of colorectal cancer screening for the intervention versus control arms were 41.3% v 32.4%, respectively (P < .05). The incremental cost-effectiveness ratio was $978 per additional veteran screened based on feedback reports generated from manual review of records. However, if feedback reports could be generated from information technology systems, sensitivity analyses indicate that the cost-effectiveness estimate would decrease to $196 per additional veteran screened. Conclusion An intervention based on quarterly feedback reports to physicians improved colorectal cancer screening rates at a VA medical center. This intervention would be cost effective if relevant data could be generated by existing information technology systems. Our findings may have broad applicability because a 2005 Medicare initiative will provide the VA electronic medical record system as a free benefit to all US physicians.

160: Cost-Effectiveness of Medical Management Strategies of Nephrolithiasis in Different Health Care Systems

2004 ◽  
Vol 171 (4S) ◽  
pp. 42-43 ◽  
Author(s):  
Yair Latan ◽  
David M. Wilhelm ◽  
David A. Duchene ◽  
Margaret S. Pearle
Keyword(s):  
Health Care ◽  
Cost Effectiveness ◽  
Medical Management ◽  
Health Care Systems ◽  
Management Strategies ◽  
Care Systems

scholarly journals Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population

2021 ◽  
pp. 1-1
Author(s):  
Deborah A. Fisher ◽  
Jordan J. Karlitz ◽  
Sushanth Jeyakumar ◽  
Nathaniel Smith ◽  
Paul Limburg ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Real World ◽  
Medicare Population

scholarly journals Use of primary health care and participation in colorectal cancer screening – a Danish national register-based study

2020 ◽  
Vol 59 (8) ◽  
pp. 1002-1006
Author(s):  
Rebecca Beatrix Clarke ◽  
Christina Therkildsen ◽  
Mie Agermose Gram ◽  
Klaus Kaae Andersen ◽  
Lina Steinrud Mørch ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Health Care ◽  
Primary Health Care ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
National Register ◽  
Primary Health

scholarly journals PCN166 Cost-Effectiveness of Colorectal Cancer Screening Program in the Czech Republic

2020 ◽  
Vol 23 ◽  
pp. S452
Author(s):  
O. Ngo ◽  
J. Kouřil ◽  
I. Svobodová ◽  
D. Krejčí ◽  
L. Dušek ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Czech Republic ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Screening Program ◽  
The Czech Republic ◽  
Cancer Screening Program

Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs

2010 ◽  
Vol 28 (27) ◽  
pp. 4149-4153 ◽  
Author(s):  
Scott R. Berry ◽  
Chaim M. Bell ◽  
Peter A. Ubel ◽  
William K. Evans ◽  
Eric Nadler ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
Cost Effectiveness ◽  
Health Care Systems ◽  
The United States ◽  
Drug Costs ◽  
Cancer Drug ◽  
Cancer Drugs ◽  
Care Systems ◽  
Effective Treatments

Purpose Oncologists in the United States and Canada work in different health care systems, but physicians in both countries face challenges posed by the rising costs of cancer drugs. We compared their attitudes regarding the costs and cost-effectiveness of medications and related health policy. Methods Survey responses of a random sample of 1,355 United States and 238 Canadian medical oncologists (all outside of Québec) were compared. Results Response rate was 59%. More US oncologists (67% v 52%; P < .001) favor access to effective treatments regardless of cost, while more Canadians favor access to effective treatments only if they are cost-effective (75% v 58%; P < .001). Most (84% US, 80% Canadian) oncologists state that patient out-of-pocket costs influence their treatment recommendations, but less than half the respondents always or frequently discuss the costs of treatments with their patients. The majority of oncologists favor more use of cost-effectiveness data in coverage decisions (80% US, 69% Canadian; P = .004), but fewer than half the oncologists in both countries feel well equipped to use cost-effectiveness information. Majorities of oncologists favor government price controls (57% US, 68% Canadian; P = .01), but less than half favor more cost-sharing by patients (29% US, 41% Canadian; P = .004). Oncologists in both countries prefer to have physicians and nonprofit agencies determine whether drugs provide good value. Conclusion Oncologists in the United States and Canada generally have similar attitudes regarding cancer drug costs, cost-effectiveness, and associated policies, despite practicing in different health care systems. The results support providing education to help oncologists in both countries use cost-effectiveness information and discuss drug costs with their patients.

Sign in / Sign up

Export Citation Format

Share Document